Comerica Bank Decreases Stock Holdings in Trupanion, Inc. (NASDAQ:TRUP)
Comerica Bank decreased its position in Trupanion, Inc. (NASDAQ:TRUP – Get Rating) by 9.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 26,862 shares of the financial services provider’s stock after selling 2,665 shares during the quarter. Comerica Bank owned approximately 0.07% of Trupanion worth $1,309,000 at the end of the most recent quarter.
→ Is This The End of Capitalism? (From Porter & Company)
A number of other hedge funds have also recently modified their holdings of TRUP. Greenhaven Road Investment Management L.P. purchased a new position in shares of Trupanion in the second quarter valued at about $32,000. Strs Ohio purchased a new position in shares of Trupanion in the third quarter valued at about $35,000. Harbor Investment Advisory LLC increased its position in shares of Trupanion by 31.9% in the second quarter. Harbor Investment Advisory LLC now owns 942 shares of the financial services provider’s stock valued at $57,000 after acquiring an additional 228 shares during the period. Prospera Financial Services Inc increased its position in shares of Trupanion by 90.9% during the second quarter. Prospera Financial Services Inc now owns 1,050 shares of the financial services provider’s stock valued at $63,000 after buying an additional 500 shares during the period. Finally, Captrust Financial Advisors increased its position in shares of Trupanion by 45.2% during the second quarter. Captrust Financial Advisors now owns 1,297 shares of the financial services provider’s stock valued at $78,000 after buying an additional 404 shares during the period. Hedge funds and other institutional investors own 97.55% of the company’s stock.
Trupanion Trading Up 2.6 %
NASDAQ:TRUP opened at $55.89 on Tuesday. Trupanion, Inc. has a one year low of $40.77 and a one year high of $99.10. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.50 and a quick ratio of 1.50. The company’s 50-day simple moving average is $51.88 and its 200 day simple moving average is $58.48. The firm has a market capitalization of $2.29 billion, a P/E ratio of -53.74 and a beta of 1.77.
Trupanion (NASDAQ:TRUP – Get Rating) last posted its quarterly earnings data on Thursday, November 3rd. The financial services provider reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.29) by ($0.03). The business had revenue of $233.76 million for the quarter, compared to the consensus estimate of $231.21 million. Trupanion had a negative return on equity of 13.12% and a negative net margin of 4.97%. As a group, analysts forecast that Trupanion, Inc. will post -1.17 EPS for the current fiscal year.
Insider Transactions at Trupanion
In other news, CEO Darryl Rawlings sold 4,000 shares of the company’s stock in a transaction that occurred on Thursday, November 3rd. The shares were sold at an average price of $44.16, for a total value of $176,640.00. Following the transaction, the chief executive officer now owns 857,109 shares in the company, valued at $37,849,933.44. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Michael Doak sold 700 shares of the business’s stock in a transaction that occurred on Thursday, January 5th. The shares were sold at an average price of $46.00, for a total transaction of $32,200.00. Following the completion of the transaction, the director now directly owns 1,682 shares of the company’s stock, valued at $77,372. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Darryl Rawlings sold 4,000 shares of the business’s stock in a transaction that occurred on Thursday, November 3rd. The shares were sold at an average price of $44.16, for a total transaction of $176,640.00. Following the transaction, the chief executive officer now directly owns 857,109 shares of the company’s stock, valued at $37,849,933.44. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 21,550 shares of company stock worth $1,088,000. Corporate insiders own 5.86% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on the stock. Piper Sandler boosted their price target on shares of Trupanion from $46.00 to $53.00 and gave the company a “neutral” rating in a research report on Tuesday, December 20th. UBS Group reduced their price target on shares of Trupanion from $80.00 to $66.00 and set a “buy” rating on the stock in a research report on Friday, November 4th. Lake Street Capital reduced their price target on shares of Trupanion to $67.00 in a research report on Friday, November 4th. Finally, StockNews.com began coverage on shares of Trupanion in a research report on Wednesday, October 12th. They set a “sell” rating on the stock. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $77.25.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to firstname.lastname@example.org.
Before you consider Trupanion, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Trupanion wasn’t on the list.
While Trupanion currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.